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MR with different degree of local and global LV remodeling. and characteristics of the 
regurgitant jet. Such, a complete characterization of the pattern of ischemic MR could aid 
to tailor the best treatment for the single patient 
1084-22 Papillary Muscle Dysfunction Attenuates lschemic 
Mitral Regurgitation in Patients With Localized Basal 
Inferior Left Ventricular Remodeling 
Takeshi Uemura, Yutaka Otsuji, Toshiro Kumanohoso, Kunitsugu Takasaki, Toshinon 
Yuasa, Woo-Shik Kim, Akira Klsanuki, Shinichi Minagoe, Robert A. Levine, Chuwa Tei, 
Kagoshima University, Kagoshima, Japan, Massachusetts General Hospital, Boston, MA 
Background: In principle, papillary muscle (PM) dysfunction could be associated with 
less mitral regurgitation (MR) because of PM elongation, attenuating tethering. However, 
variability in the degree of left ventricular (LV) remodeling can influence the relation 
between PM dysfunction and MR. We. therefore, hypothesized that PM dysfunction 
attenuates MR in patients with comparable degree of segmental basal inferior LV remcd- 
cling. 
Method: From 38 consecutive patients with previous inferior myocardial infarction. 2 
patients with global LV remodeling and 12 with only modest inferior remodeling were 
excluded. In the remaining 24 patients with significant and localized basal inferior LV 
remodeling, LV volume, mitral annular area, PM tethering distance, % systolic thickening 
of middle p&ion of medial PM and MR fraction were quantified by 2.dimensional and 
Doppler echocardiography. 
Results: % systolic PM thickening had positive and significant relation with % MR fraction 
(figure), which was best correlated with medial PM tethering distance. 
Conclusion: lschemic MR can be attenuated by PM dysfunction, reducing leaflet tether- 
Ing, in patients with localized basal inferior LV remodeling. 
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1084-23 Inhibition of the cJun N-Terminal Kinase Pathway 
Minimizes Collagen Remodeling in Aortic Regurgitant 
Hearts 
Eungsuk Lee, Sharada L. Truter, Lisa Pitlor, Zhen Huang. Anuj Gupta, Jeffrey S. Borer, 
Weill Medical College, Cornell Unwersity, New York, NY 
Background: Fibrosis associated with aortic regurgitatton (AR) shows abnormal 
fibronectin (FN) but normal collagen content. This pathologic fibrosis is important in gen- 
esis of heart failure (CHF) in AR; understanding fibrosis generation may enable specific 
therapy to retard CHF. We showed that increased FN expression by cardiac fibroblasts 
(CF) from rabbits with catheter-induced AR results from activation of the c-Jun N-terminal 
kinase (JNK) pathway, which also can upregulate collagen-specific metalloproteases 
(MMPs). To see if JNK activation of MMP is involved in minimizing collagen content in 
AR we assessed MMP-2 activity with SP600125, a specific JNK inhibitor. Methods: NL- 
CF vs AR-CF (3 pairs) from rabbits were grown in triplicate with and without 2Ofl 
SP600125. Media then were collected for 24 hr intervals wer 5 days. Enzymes were 
separated by gelatin-containing zymograms, stained with coomassie blue, destained, 
and analyzed by videodensitometry. Band intensities were normalized to total cell protein 
concentrations. Results: MMP-2 activity was upregulated in AR-CF vs NL-CF 
(AR:NL=2.1:1. p< .03). When CF were grown with SP600125, MMP-2 activity was maxi- 
mally downregulated by day 2 vs day 0 (NL, 1.0:0.4, p< ,001; AR, 1.0:0.5. p< ,001. 
Table). Conclusion In AR myocardium, fibrotic myocardium featuring abnormal FN but 
normal collagen content results in part from AR-Induced upregulation of MMP-2 by JNK 
stimulation. Inhibition of this reaction may help mitigate pathologic fibrosis and CHF. 
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1084-24 Heterogeneity of Response to Pressure Overload in 
Aortic Stenosis 
Danita M. Yoeraer, Marcia B. Leavitt, Michael H. Picard, Massachusetts General 
Hospital, Harvard Medical School, Boston, MA 
Left ventricular hypertrophy IS a ccmmcn response to the pressure overload conditions of 
acttic stenosis. The precise nature of this relationship, however has yet to be elucidated. 
Methods: We identified 265 patients referred for routine transthoracic echocardiography 
in the past 9 months who were found to have aortic stenosis with an aortic valve area 
<l .O cn? and normal regional wall motion. Patients were excluded if they had LV cavity 
dilatation suggestive of eccentric hypeltrophy (n=99) or inadequate echocardiography to 
perform the analysis(n=lO). We assessed septal wall thickness(lVS), posterior wall thick- 
ness (PWT), chamber dimensions, ejection fraction, aortic gradients, aortic valve area, 
and calculated left ventricular mass. Correlation coefficients were calculated to examine 
the relationship between wall thicknesses and peak pressure gradients(PKGR). Results: 
Of the 175 patients included in this analysis, 49% were men, and the mean age was 74 
+I- 0.9 years. While significant correlation coefficients were demonstrated for the rela- 
tionship between IVS and PKGR (R=0.27, p<O.O003), between PWT and PKGR 
(R=0.30, p<O.OOOl), and between LV mass and PKGR (R=O.26, P<O.O005), a large per- 
centage of patients failed to demonstrate hypedrophy at significant pressure gradients 
(Fig 1). Conclusion: The hypertrophic response to pressure overload in aortic stenosis 
appears heterogeneous. Other factors which influence ventricular remodeling may play a 
role in this process. 
1084-25 Effect of Candesartan Cilexetil on Left Ventricular 
Remodeling in Mitral Regurgitation: A Randomized 
Clinical Trial 
Maurice L. Enriquez-Sarano, Michael Bellamy, Jean-Francois Avierinos David L. (- 
Messika-Zeitouq Vuysile Nkomo. Mayo Clinic, Rochester, MN 
Background:The effect of tissue angiotensin blockade in Mitral Regurgitation (MR) due 
to intrinsic valve disease is disputed due to lack of randomized clinical trials. Of particular 
importance is the effect of these medications on left ventricular (LV) remodeling, ie.. on 
LV end-diastolic and end-systolic volume index (EDVI, ESVI). Candesartan Cilexetil is an 
anglotensin receptor blocker with insurmountable receptor attachment allowing prc- 
longed clinical efficacy. 
Methods: In 32 patients (age 69+14 years, 36% female) with organic MR of at least 
moderate degree, in functional Class I or II, with normal renal function (creatinine 1.1+0.2 
mg/dL), patients were randomized between placebo (n=l7) or Candesartan Cilexetil 32 
mg/daily (n=l5) treatment for 1 year. After one year the end-points of EOVI and ESVI 
were measured. 
Results:At baseline, there was no difference between placebo and Candesartan groups 
forage, sex. systolic (141*19 vs. 144i18 mmHg, P=O.69) and diastolic (74+10 vs. 77+14 
mmHg, P=O.46) blood pressure, regurgitant volume measured by 2 methods (73*25 vs. 
77*14 ml/beat, P=O.97), EDVI (103221 vs. 104+19 mUm2,) and ESVI (26+9 vs. 25tlO 
